BR112014009547A8 - composição farmacêutica para administração oral, e, sistema de liberação para a administração oral de uma composição farmacêutica bifásica - Google Patents

composição farmacêutica para administração oral, e, sistema de liberação para a administração oral de uma composição farmacêutica bifásica

Info

Publication number
BR112014009547A8
BR112014009547A8 BR112014009547A BR112014009547A BR112014009547A8 BR 112014009547 A8 BR112014009547 A8 BR 112014009547A8 BR 112014009547 A BR112014009547 A BR 112014009547A BR 112014009547 A BR112014009547 A BR 112014009547A BR 112014009547 A8 BR112014009547 A8 BR 112014009547A8
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
oral administration
delivery system
biphasic
biphasic pharmaceutical
Prior art date
Application number
BR112014009547A
Other languages
English (en)
Other versions
BR112014009547A2 (pt
Inventor
Jürgen Maier Hans
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of BR112014009547A2 publication Critical patent/BR112014009547A2/pt
Publication of BR112014009547A8 publication Critical patent/BR112014009547A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
BR112014009547A 2011-10-19 2012-10-05 composição farmacêutica para administração oral, e, sistema de liberação para a administração oral de uma composição farmacêutica bifásica BR112014009547A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161548837P 2011-10-19 2011-10-19
PCT/US2012/058829 WO2013058996A1 (en) 2011-10-19 2012-10-05 Two phase pharmaceutical delivery system

Publications (2)

Publication Number Publication Date
BR112014009547A2 BR112014009547A2 (pt) 2017-04-18
BR112014009547A8 true BR112014009547A8 (pt) 2018-01-23

Family

ID=48135086

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014009547A BR112014009547A8 (pt) 2011-10-19 2012-10-05 composição farmacêutica para administração oral, e, sistema de liberação para a administração oral de uma composição farmacêutica bifásica

Country Status (9)

Country Link
US (1) US9314441B2 (pt)
EP (1) EP2768488A4 (pt)
JP (1) JP2014530855A (pt)
CN (1) CN103957894A (pt)
AR (1) AR088369A1 (pt)
AU (1) AU2012326513B2 (pt)
BR (1) BR112014009547A8 (pt)
CA (1) CA2852447A1 (pt)
WO (1) WO2013058996A1 (pt)

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3419657A (en) 1964-06-23 1968-12-31 Dagra Nv Iodopanoic acid in a hydrogel
US4837255A (en) 1987-03-10 1989-06-06 Ciba-Geigy Corporation Palatable hypocholesterolaemic gel formulation containing a pharmaceutically acceptable non-digestible anion exchange resin
US5030454A (en) * 1987-10-26 1991-07-09 Alza Corporation Method for delivering drug in tiny pills in liquid carrier
JPH04149716A (ja) * 1990-10-15 1992-05-22 Fujitsu Ltd 情報処理装置
EP0596962A4 (en) * 1991-07-24 1997-01-15 Enzacor Pty Ltd Therapeutic compositions and methods.
US5364634A (en) * 1991-11-08 1994-11-15 Southwest Research Institute Controlled-release PH sensitive capsule and adhesive system and method
IL108366A (en) 1993-03-11 1999-11-30 Taro Vit Ind Ltd Semi-solid pharmaceutical compounds and a device for their use
SE9301489D0 (sv) * 1993-04-30 1993-04-30 Ab Astra Veterinary composition
IT1273742B (it) * 1994-08-01 1997-07-09 Lifegroup Spa Composizioni ad elevata bioadesivita' e mucoadesivita' utili per il trattamento di epitali e mucose
DE19529862A1 (de) 1995-08-14 1997-02-20 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
US6365180B1 (en) 1998-01-20 2002-04-02 Glenn A. Meyer Oral liquid compositions
US6071523A (en) * 1998-06-03 2000-06-06 Taro Pharmaceuticals Industries, Ltd. Spill resistant pharmaceutical compositions in semi-solid form
CA2243619A1 (fr) 1998-07-17 2000-01-17 Universite De Sherbrooke Hydrogels polyioniques a base de xanthane et chitosane pour stabilisation et relargage controle des vitamines
EP1124587A1 (en) * 1999-08-27 2001-08-22 Department of National Defence Hydrogel wound dressing containing liposome-encapsulated therapeutic agent
DE10224086A1 (de) 2002-05-31 2003-12-11 Bayer Ag Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker
WO2004004690A1 (en) * 2002-07-03 2004-01-15 Abbott Laboratories Liquid dosage forms of proton pump inhibitors
US7670627B2 (en) * 2002-12-09 2010-03-02 Salvona Ip Llc pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
US20040265359A1 (en) 2003-04-17 2004-12-30 Sacks Gordon S. Oral delivery formulations of L-glutamine
US20080226705A1 (en) 2004-03-31 2008-09-18 Soltero Richard A Gel delivery system for oral administration of medicaments
WO2005107713A2 (en) 2004-05-11 2005-11-17 Egalet A/S Swellable dosage form comprising gellan gum
US9492400B2 (en) * 2004-11-04 2016-11-15 Massachusetts Institute Of Technology Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
JP4987261B2 (ja) 2005-07-13 2012-07-25 株式会社 メドレックス ゲル状経口製剤
DOP2006000274A (es) 2005-12-14 2007-10-15 Sanofi Aventis Us Llc Formulación de suspensión de fexofenadina
JP2007252341A (ja) * 2006-03-24 2007-10-04 Well Haamonii:Kk 粉末嚥下補助食品
JP2008125435A (ja) * 2006-11-21 2008-06-05 Well Haamonii:Kk ゲル形成性組成物及びこの組成物を含有するゲル
US20080171110A1 (en) * 2007-01-17 2008-07-17 Geoffrey Catherwood Stuart Solids package
JP2009007262A (ja) * 2007-06-26 2009-01-15 Toyo Capsule Kk ビスホスホネート製剤
JP5320091B2 (ja) * 2009-02-02 2013-10-23 大蔵製薬株式会社 医薬成分が長期安定化された経口投与医薬ゼリー製剤
CA2838006C (en) * 2011-06-07 2020-06-02 Gelesis Ip, Lp Method for producing hydrogels

Also Published As

Publication number Publication date
US9314441B2 (en) 2016-04-19
CA2852447A1 (en) 2013-04-25
AU2012326513A1 (en) 2014-05-01
AU2012326513B2 (en) 2016-03-17
WO2013058996A1 (en) 2013-04-25
AR088369A1 (es) 2014-05-28
EP2768488A1 (en) 2014-08-27
EP2768488A4 (en) 2015-04-15
US20130098797A1 (en) 2013-04-25
JP2014530855A (ja) 2014-11-20
CN103957894A (zh) 2014-07-30
BR112014009547A2 (pt) 2017-04-18

Similar Documents

Publication Publication Date Title
IL254854B (en) Aqueous pharmaceutical formulation of tapentadol for oral administration
EP2747563A4 (en) COMPOSITIONS AND METHODS FOR ORAL ADMINISTRATION OF MEDICINAL PRODUCTS
DK2632493T3 (da) Lægemiddelindgivelsessammensætninger
EP2849770A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE DISPOSAL OF ESSENTIALLY WATER-INSOLICED MEDICINAL PRODUCTS
BR112013017169A2 (pt) composições farmacêuticas de ferro para administração oral
EP2647380A4 (en) PHARMACEUTICAL COMPOSITION WITH MOMETASON FUROAT AND AZELASTINE HYDROCHLORIDE FOR NASAL ADMINISTRATION
IL231485A (en) Oral dosage forms of medicinal preparations are resistant to abuse
BR112013014616A2 (pt) sistema terapêutico transdérmico para a administração de uma substância ativa
BRPI1007484A2 (pt) composição farmacêutica para administração oral
ZA201306395B (en) New low side effect pharmaceutical composition containing antituberculosis drugs
BR112013029199A2 (pt) sistema de distribuição de fármacos, dispositivo de distribuição de dois fármacos, método para preparar o mesmo, comprimido para administração sublingual de um ingrediente ativo, e, método para a administração de um ingrediente ativo a um indivíduo
IL236757B (en) A device for administering a drug with retention in the digestive tract
CO7020911A2 (es) Sistema para la administración de fármacos
CR20130174A (es) Sistema y composiciones mejorados para la administración transbucal de fármacos
BR112014001425A2 (pt) forma de dosagem farmacêutica, composição farmacêutica, e, composto (i) ou sal farmaceuticamente aceitável do mesmo
EP2632902A4 (en) IMPROVED ORAL ADMINISTRATION OF ORAL DRUG DELIVERY SYSTEM
SMT201600243B (it) Composizioni farmaceutiche comprendenti anakinra senza citrato
EP2567710A4 (en) AQUEOUS PHARMACEUTICAL SYSTEM FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES ON THE NAILS
UY34080A (es) Composición farmacéutica para administración oral que comprende fexofenadina y métodos de preparación
BR112013033052A2 (pt) formulações de entrega de fármaco
BR112013019283A2 (pt) composto, fármaco, composição farmacêutica e uso
DK2714042T3 (da) En analgetisk farmaceutisk sammensætning til oral administration
BR112014009547A8 (pt) composição farmacêutica para administração oral, e, sistema de liberação para a administração oral de uma composição farmacêutica bifásica
BRPI0919475A2 (pt) composição farmacêutica para administração oral
BR112015003761A2 (pt) composto, composição farmacêutica, forma unitária de dosagem, método para administrar um agente biologicamente ativo e método para preparar uma composição

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07E Notice of approval relating to section 229 industrial property law
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2482 DE 31-07-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.